| P50 | author | Rebecca KS Wong | Q57618405 |
| | Gail E Darling | Q96650314 |
| P2093 | author name string | Raymond Jang | |
| P2860 | cites work | Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial | Q28111908 |
| | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
| | Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study | Q29620647 |
| | The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. | Q31133052 |
| | Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline | Q33558036 |
| | Preoperative versus postoperative chemoradiotherapy for rectal cancer | Q34552041 |
| | Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response | Q34570217 |
| | Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 |
| | Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection | Q34638268 |
| | Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer | Q34660654 |
| | Clinical evidence for three distinct gastric cancer subtypes: time for a new approach | Q35050315 |
| | Role of post-operative chemoradiation in resected gastric cancer | Q36128348 |
| | Upper abdominal malignancies: intensity-modulated radiation therapy | Q36887037 |
| | Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. | Q36974690 |
| | Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review. | Q37127154 |
| | Requirement for a standardised definition of advanced gastric cancer. | Q37388724 |
| | Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. | Q37998931 |
| | How many lymph nodes should be assessed in patients with gastric cancer? A systematic review | Q38034917 |
| | Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis | Q38092435 |
| | Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study | Q38105723 |
| | Laparoscopic versus open gastrectomy for early gastric cancer in Asia: a meta-analysis | Q38126782 |
| | Radiotherapy for gastric cancer: a systematic review and meta-analysis | Q38127627 |
| | Prospective randomized trial of combined oncological therapy for gastric carcinoma | Q39682041 |
| | Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection | Q42790804 |
| | A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer | Q43174266 |
| | Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer | Q44125609 |
| | Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. | Q44233783 |
| | Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma | Q44978576 |
| | Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. | Q45753281 |
| | Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics | Q46321211 |
| | [Adjuvant intraoperative radiotherapy of stomach carcinoma] | Q50962256 |
| | Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncolog | Q51771070 |
| | Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. | Q53340153 |
| | Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. | Q53361535 |
| | 7th Edition of the AJCC Cancer Staging Manual: Stomach | Q55053470 |
| | The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up | Q59392009 |
| | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer | Q61868158 |
| | Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial | Q62628706 |
| | Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy | Q70287797 |
| | Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma | Q70651042 |
| | Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma | Q72428093 |
| | A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group | Q72664730 |
| | A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer | Q73213554 |
| | Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial | Q74599960 |
| | Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients | Q77737282 |
| | Seventh edition of TNM classification for gastric cancer | Q82087825 |
| | Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery | Q82621840 |
| | Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 |
| | A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection | Q84981772 |
| | Gastric cancer epidemiology and risk factors | Q85369255 |
| | Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans | Q94947088 |
| P433 | issue | 1 | |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| P304 | page(s) | 89-107 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
| P1476 | title | Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy | |
| P478 | volume | 6 | |